These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 220274

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Experimental and clinical studies with converting enzyme inhibitor.
    Haber E, Barger AC.
    Prog Biochem Pharmacol; 1976; 12():16-32. PubMed ID: 190618
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
    Atlas SA, Niarchos AP, Case DB.
    Am J Nephrol; 1983; 3(2-3):118-27. PubMed ID: 6191567
    [No Abstract] [Full Text] [Related]

  • 27. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
    Cohn JN, Levine TB.
    Am J Cardiol; 1982 Apr 21; 49(6):1480-3. PubMed ID: 6176108
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Angiotensin II inhibitors for the diagnosis and treatment of hypertension].
    Brunner HR, Gavras H.
    Schweiz Med Wochenschr; 1976 Dec 11; 106(50):1791-8. PubMed ID: 1013701
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension.
    Crantz FR, Swartz SL, Hollenberg NK, Moore TJ, Dluhy RG, Williams GH.
    Hypertension; 1980 Dec 11; 2(5):604-9. PubMed ID: 6158478
    [Abstract] [Full Text] [Related]

  • 37. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H, Uneda S, Tochikubo O, Ohonishi T, Harada J, Sesoko S, Goto E, Fujishima S, Kaneko Y.
    Nihon Jinzo Gakkai Shi; 1980 Jan 11; 22(1):13-22. PubMed ID: 6247528
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
    Case DB, Wallace JM, Laragh JH.
    Kidney Int Suppl; 1979 Mar 11; (9):S107-114. PubMed ID: 225598
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.